Skip to content

Illumina, Inc.

ILMN· NasdaqCore metricsCIK 1110803

Laboratory analytical instruments24 peers

Last sale
Nov 12, 2026 · -1.56%
Market cap
$31.68B
151.2M shares
Filings
1,085
$1.13B
Q3 2026−0.7% FY25 yoy
$220.00M
Q3 2026N/M FY25 yoy
$305.00M
Q3 2026N/M FY25 yoy
$791.00M
Q3 2026derived+31.3% FY25 yoy
$1.43
Q3 2026N/M FY25 yoy
$1.29B
Q3 2026+25.8% FY25 yoy
$31.68B
35.4×
7.0×
10.1×
3.34%
—

Twelve months to Sep 27, 2026 · derived

Price

$209.54+70.87%+$86.91past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$4.34BFY 2025
$4.58B0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-28$4,343,000,000reported
FY 20242024-12-29$4,372,000,000reported
FY 20232023-12-31$4,504,000,000reported
FY 20222023-01-01$4,584,000,000reported
FY 20212022-01-02$4,526,000,000reported
FY 20202021-01-03$3,239,000,000reported
FY 20192019-12-29$3,543,000,000reported
FY 20182018-12-30$3,333,000,000reported
FY 20172017-12-31$2,752,000,000reported
FY 20162017-01-01$2,398,000,000reported
FY 20152016-01-03$2,220,000,000reported
FY 20142014-12-28$1,861,358,000reported

Capital returns

Dividends and buybacks · FY2016 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025—$742.00M$742.00M—152.90M sh−3.5%79.7%
FY2024—$116.00M$116.00M—158.40M sh−0.3%16.4%
FY2023—$0.00$0.00—158.90M sh+0.6%0.0%
FY2022—$0.00$0.00—158.00M sh+0.6%0.0%
FY2021—$0.00$0.00—157.00M sh+7.6%0.0%

Segments

Revenue by Segments, FY2018 to FY2025FY2018Core Illumina · FY2018 · $3.33BHelix · FY2018 · $10.00MFY2019Core Illumina · FY2019 · $3.54BSequencing · FY2019 · $3.07BMicroarray · FY2019 · $475.00MHelix · FY2019 · $1.00MFY2020Core Illumina · FY2020 · $3.24BSequencing · FY2020 · $2.88BMicroarray · FY2020 · $360.00MFY2021Core Illumina · FY2021 · $4.52BSequencing · FY2021 · $4.11BMicroarray · FY2021 · $417.00MGRAIL · FY2021 · $12.00MFY2022Core Illumina · FY2022 · $4.55BSequencing · FY2022 · $4.17BMicroarray · FY2022 · $413.00MGRAIL · FY2022 · $55.00MFY2023Core Illumina · FY2023 · $4.44BSequencing · FY2023 · $4.11BMicroarray · FY2023 · $392.00MGRAIL · FY2023 · $93.00MFY2024Core Illumina · FY2024 · $4.33BSequencing · FY2024 · $3.99BMicroarray · FY2024 · $379.00MGRAIL · FY2024 · $55.00MFY2025Core Illumina · FY2025 · $4.34BSequencing · FY2025 · $3.99BMicroarray · FY2025 · $358.00M
LineFY2025ShareChange
Core Illumina$4.34B100%+0.3%
Sequencing$3.99B92%−0.2%
Microarray$358.00M8.2%−5.5%
GRAIL$0.00—−100.0%
Helix———
Total$4.34B

From the 10-K filed Feb 12, 2026ILMN

Laboratory analytical instruments

Illumina, Inc. is the 3rd largest of the 25 covered companies the SEC files under this code, by revenue. SIC 3826

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Illumina, Inc. · CIK 1110803 · Engraved from SEC EDGAR